InsiderTrades

Form 4 for JNJ Johnson & Johnson

Accepted 2025-09-03 17:13:57 ET · period of report 2025-08-29 · accession 0000200406-25-000184 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-09-03 17:13 2025-08-29 JNJ Forminard Elizabeth GC, Executive VP M - OptEx $115.67 +11.5K 22.4K +106% +$1.33M
D 2025-09-03 17:13 2025-08-29 JNJ Forminard Elizabeth GC, Executive VP F - Tax $177.20 -9,570 12.9K -43% -$1.70M
D 2025-09-03 17:13 2025-08-29 JNJ Forminard Elizabeth GC, Executive VP M - OptEx $115.67 -11.5K 0 -100% -$1.33M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-29 M A 11,521 $115.67 22,423 D — —
2 Common Common Stock 2025-08-29 F D 9,570 $177.20 12,853 D — —
3 Derivative Employee Stock Options (Right to Buy) 2025-08-29 M D 11,521 $115.67 0 D $115.67 · 2020-02-13 to 2027-02-13 11,521 Common Stock (F1) Vested and exercisable on the third anniversary of the date of the grant.